1. Home
  2. AMS vs VTGN Comparison

AMS vs VTGN Comparison

Compare AMS & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Shared Hospital Services

AMS

American Shared Hospital Services

N/A

Current Price

$1.26

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

BUY

Current Price

$0.19

Market Cap

9.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AMS
VTGN
Founded
1980
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
9.5M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
AMS
VTGN
Price
$1.26
$0.19
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $1.00
AVG Volume (30 Days)
8.8K
★ 18.0M
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $19,714,000.00
N/A
Revenue This Year
$16.37
$33.96
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 0.81
N/A
52 Week Low
$1.21
$0.19
52 Week High
$2.39
$5.14

Technical Indicators

Market Signals
Indicator
AMS
VTGN
Relative Strength Index (RSI) 29.71 33.60
Support Level N/A N/A
Resistance Level $1.52 $0.32
Average True Range (ATR) 0.05 0.02
MACD -0.01 -0.01
Stochastic Oscillator 16.32 4.96

Price Performance

Historical Comparison
AMS
VTGN

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: